tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

First SICAF Anchors Più Medical’s IPO with €4.8 Million Investment

Story Highlights
  • First SICAF invests €4.8 million in Più Medical’s IPO on Euronext Growth Milan.
  • The investment supports Più Medical’s growth, with a board appointment and lock-up commitment.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
First SICAF Anchors Più Medical’s IPO with €4.8 Million Investment

TipRanks Cyber Monday Sale

The latest announcement is out from First Capital S.p.A. ( (IT:FIC) ).

First SICAF, a vehicle of First Capital S.p.A., has invested 4.8 million euros as an anchor investor in Più Medical S.p.A., a leading group in the Italian pharmacy sector, as part of its IPO on Euronext Growth Milan. This strategic investment aims to support Più Medical’s growth and includes a board appointment and a 12-month lock-up commitment, highlighting First SICAF’s confidence in Più Medical’s expansion plans and market positioning.

The most recent analyst rating on (IT:FIC) stock is a Buy with a EUR30.40 price target. To see the full list of analyst forecasts on First Capital S.p.A. stock, see the IT:FIC Stock Forecast page.

More about First Capital S.p.A.

First Capital S.p.A. is a financial holding company specializing in Private Investments in Public Equity and Private Equity investments, focusing on small and medium-sized listed companies, particularly those in the pre-IPO phase or interested in future listings. The company employs an active investment management approach, often seeking roles in the boards or control bodies of target companies to enhance long-term value.

Average Trading Volume: 2,610

Technical Sentiment Signal: Buy

Current Market Cap: €66.28M

Find detailed analytics on FIC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1